Oncotherapeutics (United States)
- World rank, all time
- #27,602 of 42,892
- Rank in United States
- #5,918 of 8,685
- Research works
- 165 ▲ 24% vs 2013–17
- Citations
- 3.5k 21.1 per fractional work
- Top-10% rate
- 4.8% record average 16.5%
- Open access
- 35% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 8.7×. Every wedge is a field page.
- Veterinary 8.7×
- Immunology and Microbiology 8.3×
- Biochemistry, Genetics and Molecular Biology 3.5×
- Pharmacology, Toxicology and Pharmaceutics 3.3×
- Neuroscience 3.1×
- Medicine 2.8×
- Psychology 1.5×
- Nursing 0.8×
- Decision Sciences 0.7×
- Physics and Astronomy 0.3×
- Health Professions 0.3×
- Economics, Econometrics and Finance 0.3×
- Chemistry 0.2×
- Arts and Humanities 0.2×
- Computer Science 0.2×
- Social Sciences 0.1×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.1×
Who are the top researchers at Oncotherapeutics (United States)?
Ranked on the composite score, Regina A. Swift lead among researchers whose main affiliation is Oncotherapeutics (United States).
- 1 Regina A. Swift United States · #835,587 worldwide 43 citations · 17 works
Which keywords describe research at Oncotherapeutics (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Proteasome Inhibitors, Minimal Residual Disease, Diagnosis Criteria, International Myeloma Working Group, Cancer, Tumor Microenvironment, Inflammation and Angiogenesis.
- Transcranial Magnetic Stimulation
- Tumor Regression
- Immunotherapy
- Epidemiology
- Immunosuppression
- BET Bromodomains
- Transcriptional Regulation
- Cancer Therapy
- Angiogenesis
- Inflammation
- Minimal Residual Disease
- Diagnosis Criteria
- Proteasome Inhibitors
- International Myeloma Working Group
- Cancer
- Tumor Microenvironment
- Cancer Immunotherapy
- PET Imaging
- Lymphoma
- Immunity
- PROTACs
- Glycosylation
- Therapeutic Targets
- Transcranial Direct Current Stimulation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 24 words, with their numbers
- Proteasome Inhibitors4▲ 210×2 topics
- Diagnosis Criteria4▲ 375×1 topic
- International Myeloma Working Group4▲ 375×1 topic
- Minimal Residual Disease4▲ 195×2 topics
- Cancer3▲ 6.8×12 topics
- Inflammation2▲ 4.0×14 topics
- Tumor Microenvironment2▲ 14×6 topics
- Angiogenesis2▲ 17×4 topics
- Cancer Immunotherapy2▲ 37×3 topics
- Cancer Therapy2▲ 9.3×4 topics
- PET Imaging2▲ 31×3 topics
- Transcriptional Regulation1▲ 31×3 topics
- Lymphoma1▲ 28×2 topics
- BET Bromodomains1▲ 148×1 topic
- Immunity1▲ 11×4 topics
- Immunosuppression1▲ 49×4 topics
- PROTACs1▲ 148×1 topic
- Epidemiology1◆ 0.96×9 topics
- Glycosylation1▲ 33×2 topics
- Immunotherapy1▲ 5.5×2 topics
- Therapeutic Targets1▲ 25×4 topics
- Tumor Regression1▲ 36×2 topics
- Transcranial Direct Current Stimulation1▲ 126×1 topic
- Transcranial Magnetic Stimulation1▲ 126×1 topic
Which research topics does Oncotherapeutics (United States) publish most on?
By volume in 2022–2025: Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Transcranial Magnetic Stimulation Studies and Myeloproliferative Neoplasms: Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Multiple Myeloma Research and Treatments Hematology 4 works
- 2 Protein Degradation and Inhibitors Molecular Biology 1 works
- 3 Transcranial Magnetic Stimulation Studies Neurology 1 works
- 4 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 1 works
- 5 Peptidase Inhibition and Analysis Oncology 1 works
- 6 CAR-T cell therapy research Oncology 1 works
- 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 8 Chronic Lymphocytic Leukemia Research Genetics 0 works
- 9 Galectins and Cancer Biology Immunology 0 works
- 10 Kawasaki Disease and Coronary Complications Surgery 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Oncotherapeutics (United States)'s research output changed?
Output in 2018–2022 was 24% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Hollywood
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.